Original document(27 pages)  中文版
    The invention is directed to tricyclic indoloazepine compounds useful as vasopressin receptor antagonists, pharmaceutical compositions comprising the compounds of the present invention and methods of treating conditions involving increased vascular resistance and cardiac insufficiency which include hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, Cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, stroke, thrombosis or water retention in a subject in need thereof.
Application Number
申请号
00811602 Application Date
申请日
2000.06.15
Title 名称 Indoloazepines as vasopressin receptor antagonists
Publication Number
公开号
1399638 Publication Date
公开日
2003.02.26
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K31/55;A61P9/12;C07D487/06
Applicant(s) Name
申请人
Ortho-McNeil Pharmaceutical, Inc.
Address 地址
Inventor(s) Name 发明人 W.J. Hoekstra;M.N. Greco;L.R. Hecker
Attorney & Agent 代理人 zhang yuanzhong zhong shouqi
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.